Hana Pharm Co., Ltd. (KRX: 293480)
South Korea
· Delayed Price · Currency is KRW
10,770
-40 (-0.37%)
Nov 15, 2024, 3:30 PM KST
Hana Pharm Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2017 | FY 2016 |
---|---|---|---|
Period Ending | Dec '17 Dec 31, 2017 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
Net Income | 24,305 | 24,305 | 17,431 |
Depreciation & Amortization | 3,522 | 3,522 | 3,678 |
Loss (Gain) From Sale of Assets | -234.01 | -234.01 | 19.1 |
Asset Writedown & Restructuring Costs | - | - | 108.48 |
Provision & Write-off of Bad Debts | -389.2 | -389.2 | 201.78 |
Other Operating Activities | 1,832 | 1,832 | -969.09 |
Change in Accounts Receivable | -2,737 | -2,737 | -9,190 |
Change in Inventory | -1,243 | -1,243 | -3,641 |
Change in Accounts Payable | 444.72 | 444.72 | 574.97 |
Change in Other Net Operating Assets | -119.39 | -119.39 | 4,251 |
Operating Cash Flow | 25,380 | 25,380 | 12,464 |
Operating Cash Flow Growth | - | 103.63% | - |
Capital Expenditures | -10,193 | -10,193 | -8,310 |
Sale of Property, Plant & Equipment | 102.56 | 102.56 | 33.7 |
Cash Acquisitions | 360 | 360 | - |
Sale (Purchase) of Intangibles | -1,228 | -1,228 | -51.91 |
Investment in Securities | -1,842 | -1,842 | 962.41 |
Other Investing Activities | -17.23 | -17.23 | -475.77 |
Investing Cash Flow | -12,818 | -12,818 | -9,310 |
Short-Term Debt Issued | 1,006 | 1,006 | 3,398 |
Long-Term Debt Issued | 500 | 500 | 4,000 |
Total Debt Issued | 1,506 | 1,506 | 7,398 |
Short-Term Debt Repaid | -1,019 | -1,019 | -5,214 |
Long-Term Debt Repaid | -2,367 | -2,367 | -6,398 |
Total Debt Repaid | -3,386 | -3,386 | -11,612 |
Net Debt Issued (Repaid) | -1,880 | -1,880 | -4,215 |
Issuance of Common Stock | 1,892 | 1,892 | 1,862 |
Dividends Paid | -1,023 | -1,023 | - |
Other Financing Activities | 0.81 | 0.81 | 19.24 |
Financing Cash Flow | -1,011 | -1,011 | -2,334 |
Miscellaneous Cash Flow Adjustments | 0 | 0 | - |
Net Cash Flow | 11,551 | 11,551 | 820.74 |
Free Cash Flow | 15,187 | 15,187 | 4,154 |
Free Cash Flow Growth | - | 265.64% | - |
Free Cash Flow Margin | 10.90% | 10.90% | 3.34% |
Free Cash Flow Per Share | 1401.56 | 1401.56 | 535.67 |
Cash Interest Paid | 1,083 | 1,083 | 1,426 |
Cash Income Tax Paid | 5,814 | 5,814 | 6,531 |
Levered Free Cash Flow | 7,304 | 7,304 | - |
Unlevered Free Cash Flow | 7,957 | 7,957 | - |
Change in Net Working Capital | 4,025 | 4,025 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.